echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > The Drug Administration adjusts part of the Sub-Catalog of 6840 In-body Diagnostic Reagents Classification (2013 Edition).

    The Drug Administration adjusts part of the Sub-Catalog of 6840 In-body Diagnostic Reagents Classification (2013 Edition).

    • Last Update: 2020-10-31
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    On October 21, the State Drug Administration issued a notice on the adjustment of the sub-catalogue of 6840 in-body diagnostic reagents (2013 edition) (No. 112 of 2020).
    . The contents of the adjustment are adjusted to the management category and intended use of some in-body diagnostic reagents in the Product Category III-7 reagents related to tumor markers in the Sub-Catalog of 6840 In-body Diagnostic Reagents, as detailed in the annex.
    II. Implementation requirements (1) From the date of the issuance of this announcement, the drug regulatory department shall, in accordance with the Measures for the Administration of the Registration of In-body Diagnostic Reagents, the Amendments to the Measures for the Registration and Administration of In-body Diagnostic Reagents, and the Announcement on the Requirements for the Publication of the Registration and Declaration of In-body Diagnostic Reagents and the Approval of the Document Format, accept the registration of in-body diagnostic reagents in accordance with the adjusted categories for review and approval.
    (2) For in-body diagnostic reagents that have not yet been approved for registration, the drug regulatory department shall continue to approve the medical device registration in accordance with the original acceptance category, issue the medical device registration certificate, and indicate the adjusted product management category in the registration certificate comments column.
    (iii) For registered in-body diagnostic reagents, if the management category is adjusted from high to low, the medical device registration certificate shall remain in effect for the duration of the validity period.
    If renewal is required, the registrar shall apply to the corresponding drug regulatory department for renewal of registration in accordance with the changed category six months before the expiration of the validity period of the medical device registration certificate, and if the renewal registration is granted, the medical device registration certificate shall be issued in accordance with the adjusted product management category.
    change of registration occurs within the validity period of the medical device registration certificate, the registrar shall apply to the original registration department for a change in registration.
    (5) The provincial drug supervision and administration departments shall strengthen the publicity training for the adjustment of the category adjustment of the sub-catalogue of 6840 in vitro diagnostic reagents (2013 edition) and effectively do a good job in the review and approval of relevant products and post-market supervision.
    this announcement shall be implemented from the date of publication.
    : 6840 in-body diagnostic reagent classification sub-catalog part of the adjustment table source: State Drug Administration
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.